BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6163894)

  • 1. [Modification of a micromethod for determining leukocyte migration inhibition and its significance in oncological patients].
    Kochetkova VA
    Lab Delo; 1980; (12):744-6. PubMed ID: 6163894
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
    Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
    Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
    Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
    Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
    [No Abstract]   [Full Text] [Related]  

  • 5. Formalinized tumour cells in the leucocyte migration inhibition test.
    Ross CE; Cochran AJ; Hoyle DE; Grant RM; Mackie RM
    Clin Exp Immunol; 1975 Oct; 22(1):126-32. PubMed ID: 1212813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic mechanisms in malignant melanoma of the skin.
    Cochran AJ
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):385-8. PubMed ID: 347641
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of ovarian carcinoma tissue culture in the leukocyte migration inhibition test].
    Tosner J; Fixa B; Jirkalová V; Donát J
    Cas Lek Cesk; 1987 Apr; 126(14):439-41. PubMed ID: 3581139
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of human leukocyte migration in agarose by KC1 extracts of lung cancer.
    Boddie AW; Holmes EC; Roth JA
    Surg Forum; 1974; 25(0):109-10. PubMed ID: 4439134
    [No Abstract]   [Full Text] [Related]  

  • 9. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
    Schmeisser G; Kademann J
    Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immunity to breast carcinoma and malignant melanoma.
    Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
    Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukocyte migration inhibition in women with tumors in an environment with ovarian carcinoma antigen and encephalitogenic factor].
    Tosner J; Fixa B
    Cas Lek Cesk; 1984 Mar; 123(12):354-7. PubMed ID: 6085556
    [No Abstract]   [Full Text] [Related]  

  • 12. [Leukocyte adhesion suppression reaction for determining the immunological reactivity of oncological patients].
    Frolova LM; Govallo VI
    Vopr Onkol; 1978; 24(5):10-4. PubMed ID: 351953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dependence of leukocyte migration inhibition on the progress and activity of gynecological tumours (author's transl)].
    Tosner J; Fixa B
    Cesk Gynekol; 1979 Sep; 44(8):587-91. PubMed ID: 498305
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sensitization study of oncological patients to bacterial allergens with the aid of the leukocyte migration inhibition reaction].
    Kochetkova VA; Znamenskaia IN
    Vopr Onkol; 1981; 27(2):39-43. PubMed ID: 7210594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
    Tosner J; Fixa B
    Clin Exp Immunol; 1979 Nov; 38(2):356-60. PubMed ID: 527267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of the concentration and origin of antigens on leukocyte migration in women with malignant gynecologic tumors].
    Tosner J; Fixa B
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1980; 23(2):121-7. PubMed ID: 6969923
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leukocyte migration inhibition reaction in melanoma].
    Kovaleva VL
    Vopr Onkol; 1978; 24(1):38-42. PubMed ID: 636368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers.
    Wolberg WH
    Cancer Res; 1971 Jun; 31(6):798-802. PubMed ID: 4326036
    [No Abstract]   [Full Text] [Related]  

  • 19. Leucocyte migration inhibition test in patients with gynaecologic malignancy.
    Tosner J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(4):415-89. PubMed ID: 6978511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunologic response in patients with melanoma of the skin].
    Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
    Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.